Suchergebnisse - "Annals of oncology"

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types von McGrail, D J, Pilié, P G, Rashid, N U, Voorwerk, L, Slagter, M, Kok, M, Jonasch, E, Khasraw, M, Heimberger, A B, Lim, B, Ueno, N T, Litton, J K, Ferrarotto, R, Chang, J T, Moulder, S L, Lin, S-Y

    ISSN: 1569-8041, 1569-8041
    Veröffentlicht: England 01.05.2021
    Veröffentlicht in Annals of oncology (01.05.2021)
    “… High tumor mutation burden (TMB-H) has been proposed as a predictive biomarker for response to immune checkpoint blockade (ICB), largely due to the potential …”
    Weitere Angaben
    Journal Article
  13. 13
  14. 14

    Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set von Klein, E A, Richards, D, Cohn, A, Tummala, M, Lapham, R, Cosgrove, D, Chung, G, Clement, J, Gao, J, Hunkapiller, N, Jamshidi, A, Kurtzman, K N, Seiden, M V, Swanton, C, Liu, M C

    ISSN: 1569-8041, 1569-8041
    Veröffentlicht: 01.09.2021
    Veröffentlicht in Annals of oncology (01.09.2021)
    “… A multi-cancer early detection (MCED) test used to complement existing screening could increase the number of cancers detected through population screening, …”
    Weitere Angaben
    Journal Article
  15. 15

    Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 von Burstein, H J, Curigliano, G, Thürlimann, B, Weber, W P, Poortmans, P, Regan, M M, Senn, H J, Winer, E P, Gnant, M

    ISSN: 1569-8041, 1569-8041
    Veröffentlicht: England 01.10.2021
    Veröffentlicht in Annals of oncology (01.10.2021)
    “… The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held virtually, owing to the global COVID-19 pandemic. More than 3300 …”
    Weitere Angaben
    Journal Article
  16. 16

    ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group von Pascual, J, Attard, G, Bidard, F-C, Curigliano, G, De Mattos-Arruda, L, Diehn, M, Italiano, A, Lindberg, J, Merker, J D, Montagut, C, Normanno, N, Pantel, K, Pentheroudakis, G, Popat, S, Reis-Filho, J S, Tie, J, Seoane, J, Tarazona, N, Yoshino, T, Turner, N C

    ISSN: 1569-8041, 1569-8041
    Veröffentlicht: 01.08.2022
    Veröffentlicht in Annals of oncology (01.08.2022)
    “… Circulating tumour DNA (ctDNA) assays conducted on plasma are rapidly developing a strong evidence base for use in patients with cancer. The European Society …”
    Weitere Angaben
    Journal Article
  17. 17

    Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China von Zhang, L, Zhu, F, Xie, L, Wang, C, Wang, J, Chen, R, Jia, P, Guan, H Q, Peng, L, Chen, Y, Peng, P, Zhang, P, Chu, Q, Shen, Q, Wang, Y, Xu, S Y, Zhao, J P, Zhou, M

    ISSN: 1569-8041, 1569-8041
    Veröffentlicht: England 01.07.2020
    Veröffentlicht in Annals of oncology (01.07.2020)
    “… Cancer patients are regarded as a highly vulnerable group in the current Coronavirus Disease 2019 (COVID-19) pandemic. To date, the clinical characteristics of …”
    Weitere Angaben
    Journal Article
  18. 18

    Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group von Mosele, F, Remon, J, Mateo, J, Westphalen, C B, Barlesi, F, Lolkema, M P, Normanno, N, Scarpa, A, Robson, M, Meric-Bernstam, F, Wagle, N, Stenzinger, A, Bonastre, J, Bayle, A, Michiels, S, Bièche, I, Rouleau, E, Jezdic, S, Douillard, J-Y, Reis-Filho, J S, Dienstmann, R, André, F

    ISSN: 1569-8041, 1569-8041
    Veröffentlicht: England 01.11.2020
    Veröffentlicht in Annals of oncology (01.11.2020)
    “… Next-generation sequencing (NGS) allows sequencing of a high number of nucleotides in a short time frame at an affordable cost. While this technology has been …”
    Weitere Angaben
    Journal Article
  19. 19
  20. 20